ConductScience.org, home

Paper2438696

Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.

Cease KB and 9 others. Proc Natl Acad Sci U S A, 1987. Cited by 224 papers, by iCite.

Cite this record

ConductScience Library. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Papers, record 2438696. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2438696

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
224
iCite
Relative citation ratio, by iCite
4.77
iCite
Revised in PubMed
2019-05-01
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cease KBK B
2Margalit HH
3Cornette JLJ L
4Putney SDS D
5Robey WGW G
6Ouyang CC
7Streicher HZH Z
8Fischinger PJP J
9Gallo RCR C
10DeLisi CC

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
AntigensMajor topic
EpitopesMajor topic
HIVMajor topic
Immunity, ActiveMajor topic
Receptors, VirusMajor topic
T-Lymphocytes, Helper-InducerMajor topic
Vaccines, SyntheticMajor topic
Viral Envelope ProteinsMajor topic
Amino Acid Sequence
Animals
Mice
Mice, Inbred Strains
Protein Conformation
Recombinant Proteins
Species Specificity

Source PubMed

Download CSV of topics

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12578227Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).Science1985https://conductscience.org/library/papers/2578227PubMed
26208279Characterization of the murine TH response to influenza virus hemagglutinin: evidence for three major specificities.J Immunol1984https://conductscience.org/library/papers/6208279PubMed
32578615Complete nucleotide sequence of the AIDS virus, HTLV-III.Nature1985https://conductscience.org/library/papers/2578615PubMed
42982104Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.Nature1985https://conductscience.org/library/papers/2982104PubMed
52858740Deficient LAV1 neutralising capacity of sera from patients with AIDS or related syndromes.Lancet1985https://conductscience.org/library/papers/2858740PubMed
62988795HTLV-III env gene products synthesized in E. coli are recognized by antibodies present in the sera of AIDS patients.Cell1985https://conductscience.org/library/papers/2988795PubMed
72409209
Distinct recognition phenotypes exist for T cell clones specific for small peptide regions of proteins. Implications for the mechanisms underlying major histocompatibility complex-restricted antigen recognition and clonal deletion models of immune response gene defects.
J Exp Med1985https://conductscience.org/library/papers/2409209PubMed
82989706Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.Nature1985https://conductscience.org/library/papers/2989706PubMed
92989707HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex.Nature1985https://conductscience.org/library/papers/2989707PubMed
102410114Subunit vaccines against exogenous retroviruses: overview and perspectives.Cancer Res1985https://conductscience.org/library/papers/2410114PubMed
112410115Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).Cancer Res1985https://conductscience.org/library/papers/2410115PubMed
122410982Intrinsic and extrinsic factors in protein antigenic structure.Science1985https://conductscience.org/library/papers/2410982PubMed
132411806T cell clones to two major T cell epitopes of myoglobin: effect of I-A/I-E restriction on epitope dominance.J Immunol1985https://conductscience.org/library/papers/2411806PubMed
142413457T-cell antigenic sites tend to be amphipathic structures.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/2413457PubMed
156085753The antigenic structure of proteins: a reappraisal.Annu Rev Immunol1984https://conductscience.org/library/papers/6085753PubMed
162999596The prospects for and pathways toward a vaccine for AIDS.N Engl J Med1985https://conductscience.org/library/papers/2999596PubMed
172419430Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.J Immunol1986https://conductscience.org/library/papers/2419430PubMed
183485173Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.J Exp Med1986https://conductscience.org/library/papers/3485173PubMed
193006246Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.Science1986https://conductscience.org/library/papers/3006246PubMed
202420472The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.Cell1986https://conductscience.org/library/papers/2420472PubMed

See all 50 referencesDownload CSV of references

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 224 citations.

PMIDTitleJournalYearIn PapersSource
34400018A large repertoire of B cell lineages targeting one cluster of epitopes in a vaccinated rhesus macaque.Vaccine2021https://conductscience.org/library/papers/34400018PubMed
27102818Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptides.Vaccine2016https://conductscience.org/library/papers/27102818PubMed
26251831Structural analysis of a novel rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region critical for receptor and co-receptor binding.Emerg Microbes Infect2015https://conductscience.org/library/papers/26251831PubMed
24186049Modelling of peptide and protein structures.Amino Acids1994https://conductscience.org/library/papers/24186049PubMed
17301218
Low maternal viral loads and reduced granulocyte-macrophage colony-stimulating factor levels characterize exposed, uninfected infants who develop protective human immunodeficiency virus type 1-specific responses.
Clin Vaccine Immunol2007https://conductscience.org/library/papers/17301218PubMed
17208967Molecular analysis of TCR and peptide/MHC interaction using P18-I10-derived peptides with a single D-amino acid substitution.Biophys J2007https://conductscience.org/library/papers/17208967PubMed
16672644Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.J Neurosci2006https://conductscience.org/library/papers/16672644PubMed
15266112Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children.Virus Genes2004https://conductscience.org/library/papers/15266112PubMed
14641916Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity.J Immune Based Ther Vaccines2003https://conductscience.org/library/papers/14641916PubMed
11956295Structural basis of cytochrome c presentation by IE(k).J Exp Med2002https://conductscience.org/library/papers/11956295PubMed
11339361HIV vaccine development at Duke University Medical Center.Immunol Res2000https://conductscience.org/library/papers/11339361PubMed
11298132Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission.Clin Exp Immunol2001https://conductscience.org/library/papers/11298132PubMed
11287569Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.J Virol2001https://conductscience.org/library/papers/11287569PubMed
10590113
Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains.
J Virol2000https://conductscience.org/library/papers/10590113PubMed
9847381
Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodies.
J Virol1999https://conductscience.org/library/papers/9847381PubMed
9697988Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens.Clin Exp Immunol1998https://conductscience.org/library/papers/9697988PubMed
9380724Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9380724PubMed
8356059
Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8356059PubMed
8113410Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.J Clin Invest1994https://conductscience.org/library/papers/8113410PubMed
7679708Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.J Exp Med1993https://conductscience.org/library/papers/7679708PubMed

See all 52 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2438696

GET https://conductscience.org/api/papers/v1/2438696/references?page=2